scholarly journals Serbian Translation and Validation of SF-36 for Assessment of Quality of Life in Patients with Diagnosed Arterial Hypertension

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Aleksandra Nikolic ◽  
Vladimir Biocanin ◽  
Nemanja Rancic ◽  
Mirjana Duspara ◽  
Dusan Djuric
Keyword(s):  
Arterial Hypertension ◽  
Test Validity ◽  
Life Quality ◽  
Special Importance ◽  
Validity And Reliability ◽  
Alpha Coefficient ◽  
Internal Reliability ◽  
Questionnaire Measure ◽  
Sf 36 ◽  
Serbian Version

Abstract Precise estimation of life quality is of special importance in patients with chronic diseases, such as arterial hypertension. There are many questionnaires for that purpose. SF 36 with 8 domains has been proved as one of the most appropriate. To date, there was no translated and validated SF 36 in the Serbian language for hypertensive patients. The aim of this study was to test validity and reliability of the SF-36 in Serbian patients with diagnosed arterial hypertension. Cronbach’s alpha coefficient was calculated to assess the internal consistency of the Serbian version of the SF-36. After deducting the overlap between each of the 36 items and its related domain, the collective validity was considered to be good if the correlation coefficient remains > 0.4. Only 2.54% answers to the questions were missing. The values of all 8 domains were higher in men than in women. Cronbach alpha coefficient was high for the SF-36, 0.897, and it suggests that the SF-36 had good internal reliability. All 8 domains showed high values of non-rotating factorial weights (>0.300) (range from 0.742-0.856), and all measure the same thing. It means that all components in this questionnaire measure the things they are assigned to.

Influence of the temperature factor in the Far North on meteosensitive patients with arterial hypertension

2021 ◽  
Vol 19 (1) ◽  
pp. 69-74
Author(s):  
E. G. Ivanova ◽  
◽  
T. E. Potemina ◽  
E. V. Makarova ◽  
◽  
...  
Keyword(s):  
Arterial Hypertension ◽  
Ambient Temperature ◽  
Control Charts ◽  
Average Duration ◽  
Life Quality ◽  
Meteorological Conditions ◽  
Slip Effect ◽  
Far North ◽  
Sf 36 ◽  
Clinical Variants

The purpose is to study the effect of ambient temperature in the Far North on meteosensitive patients with various degrees and clinical variants of arterial hypertension. Material and methods. 250 people took part in the study — 142 men (56,8%) and 108 women (43,2%), permanently residing in the territory of KhMAO-UGRA. All patients had a confirmed diagnosis of Grade 1-3 arterial hypertension (AH). The average age is not younger than 18 and not older than 75 years. The average duration of hypertension was 15,7 (0,5) years (p = 0,9). Also, the duration of observation of all patients was taken into account according to control charts (CC). The sample ranged from 6 months to 3 years. The assessment of the meteorological conditions influence was carried out using test indices: A. Grigoriev’s test-index, D. Rudder’s kerosotropic test-index, and I. Kerdo’s vegetative test-index. The indicators of life quality were assessed using the MOS SF-36 questionnaire. Results. The development of meteotropic reactions, including arterial pressure slip effect (APSE), in meteosensitive patients was 2 times more often observed in women with AH 2 and 3 degrees, on the days of the passage of cyclones and anticyclones. Conclusion. The ambient temperature is a predictor of meteotropic reactions in meteosensitive patients with hypertension permanently living in the Far North. The CC method allows identifying the periods of APSE and developing a predictive model.

Russian Version of Oswestry Questionnaire: Test Validity and Reliability

2011 ◽  
Vol 18 (1) ◽  
pp. 73-79
Author(s):  
Evgeniy Arkad'evich Cherepanov ◽  
E A Cherepanov
Keyword(s):  
Test Validity ◽  
Scientific Work ◽  
Low Back ◽  
Validity And Reliability ◽  
Russian Version ◽  
Sf 36 ◽  
Questionnaire Version ◽  
Consistency Of The Test ◽  
Questionnaire Disability ◽  
Test Correlation

The purpose of the study was the evaluation of Russian Oswestry questionnaire (disability index) version 2.1a reliability. Evaluation was performed on the basis of prospective cohort examination of 101 patients. All patients were questioned at the time of first examination, within 2-5 days after first visit and after completion treatment. Repetition of results, internal consistency of the test, correlation with visual analog scale (VAS) and SF-36 questionnaire subscales were studied. Repetition of results made up 0.96, Cronbach's a coefficient - 0.919, correlation with VAS - 0.668. Adapted of Russian Oswestry questionnaire version 2.1a is a valid and reliable tool. It is recommended for application in practical and scientific work for the evaluation of vital activity disturbances in patients with low back pains. The study was approved by Prof. J. Fairbank, the author of Oswestry questionnaire.

Developmental and Initial Validation of the Pulmonary Arterial Hypertension Symptom Interference Scale

2016 ◽  
Vol 24 (1) ◽  
pp. 40-53
Author(s):  
Lea Ann Matura ◽  
Annette McDonough ◽  
Alexandra L Hanlon ◽  
Diane L. Carroll
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Short Form ◽  
Principal Component ◽  
Validity And Reliability ◽  
Medical Outcomes ◽  
Targeted Interventions ◽  
Sf 36 ◽  
Pulmonary Arterial ◽  
The Impact

Background: Pulmonary arterial hypertension is a chronic illness that produces multiple symptoms and impairs quality of life. Purpose: The purpose of this study was to describe the initial psychometric properties of the Pulmonary Arterial Hypertension Symptom Interference Scale (PAHSIS). Methods: Participants completed a sociodemographic and clinical data form: the PAHSIS and the Medical Outcomes Study Short Form-36 (SF-36). Data analysis included descriptive statistics, principal component analysis (PCA), and Pearson r correlations. Results: PCA revealed a 3-factor solution: Cardiopulmonary, Weary, and Gastric. Correlations between the 3 factors and the SF-36 subscales and composite summary scores ranged from acceptable to high. Conclusions: These findings support the initial validity and reliability of the PAHSIS. Nursing can use the PAHSIS to assess the impact of patient symptoms to deploy effective, targeted interventions.

Validity and Reliability of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)

GeroPsych ◽  
2019 ◽  
Vol 32 (3) ◽  
pp. 145-151
Author(s):  
Mahshid Foroughan ◽  
Zahra Jafari ◽  
Ida Ghaemmagham Farahani ◽  
Vahid Rashedi
Keyword(s):  
Psychometric Properties ◽  
Elderly Population ◽  
Formal Education ◽  
The Elderly ◽  
Cognitive State ◽  
Validity And Reliability ◽  
Internal Reliability ◽  
Dsm Iv ◽  
Test Retest Reliability ◽  
Farsi Version

Abstract. This study examines the psychometric properties of the IQCODE and its applicability in the Iranian elderly population. A group of 95 elderly patients with at least 4 years of formal education who fulfilled the criteria of DSM-IV-TR for dementia were examined by the MMSE and the AMTs. The Farsi version of the IQCODE was subsequently administered to their primary caregivers. Results showed a significant correlation ( p = .01) between the score of the questionnaire and the results of the MMSE ( r = −0.647) and AMTs ( r = −0.641). A high internal reliability of the questionnaire was confirmed by Cronbach’s alpha coefficient (α = 0.927) and test-retest reliability by correlation coefficient ( r = 0.81). This study found that the IQCODE has acceptable psychometric properties and can be used for evaluating the cognitive state in the elderly population of Iran.

Quality of life of patients with Sjogren’s disease with ongoing therapy with diseasemodifying antirheumatic drugs

2020 ◽  
pp. 33-38
Author(s):  
E. Yu. Gan ◽  
L. P. Evstigneeva
Keyword(s):  
Quality Of Life ◽  
Short Form ◽  
Life Quality ◽  
Well Being ◽  
Disease Modifying Antirheumatic Drugs ◽  
Antirheumatic Drugs ◽  
Sf 36 ◽  
Disease Modifying ◽  
Sjögren’S Disease

Purpose of the study. Assessing the association between the life quality of patients with Sjogren’s Disease and ongoing therapy with various disease-modifying antirheumatic drugs.Material and methods. The study was conducted on the basis of the regional rheumatology center of the consultative diagnostic clinic of the Sverdlovsk Regional Clinical Hospital No. 1. This work is based on the results of a simultaneous study of 74 patients with primary Sjogren’s Disease (SD), distributed in three comparison groups receiving various disease-modifying antirheumatic drugs chlorambucil, methotrexate and hydroxychloroquine. The diagnosis of SD was carried out according to European-American criteria AECGC (2002) [18]. In order to analyze the quality of life of patients with SD, the 36-Item Short Form Health Survey (SF‑36) was used. Statistical data processing was carried out using Statistica 7.0 program.Results. Assessment of the quality of life of patients with SD, which is an integrative criterion of human health and well-being, revealed the absence of statistically significant differences (p > 0.05) on eight scales and two health components of the SF‑36 questionnaire in the analyzed groups that differ in the treatment of disease-modifying antirheumatic drugs chlorambucil, methotrexate and hydroxychloroquine.Conclusions. The obtained data indicate an equivalent quality of life in SD patients treated with different disease-modifying antirheumatic drugs methotrexate, chlorambucil and hydroxychloroquine, and therefore hydroxychloroquine can be considered as an alternative basic therapy in patients with SD with certain limitations and contraindications methotrexate and chlorambucil.

Assessment of the quality of life in the treatment approaches of patients with the comorbid course of arterial hypertension and metabolic disorders aimed at reducing cardiovascular risk

2021 ◽  
Vol 28 (Supplement_1) ◽  
Author(s):  
V Zlatkina ◽  
V Shkapo ◽  
A Nesen ◽  
T Starchenko
Keyword(s):  
Quality Of Life ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Arterial Hypertension ◽  
Metabolic Disorders ◽  
Clinical Signs ◽  
Blood Analysis ◽  
Sf 36 ◽  
Artery Disease

Abstract Funding Acknowledgements Type of funding sources: None. Introduction. Cardiovascular diseases (CVD) remain the leading cause of premature death worldwide. According to epidemiological studies CVD prevention is highly effective. A 50% reduction in mortality from coronary artery disease (CAD) is associated with exposure to risk factors and only 40% with improved treatment. Purpose.  To assess the quality of life (QOL) in patients with arterial hypertension (AH) and metabolic disorders, to establish its impact on therapy effectiveness. We examined 280 patients with AH and comorbidity - 171 women and 109 men aged 45-75 years. Along with AH, all patients had comorbidities: 72.6 % suffered from coronary artery disease (CAD), 10.5% after myocardial infarction (MI), 35 % had clinical signs of heart failure (HF), 22, 1% - type 2 diabetes mellitus (t2DM), 27.4% - chronic kidney disease (CKD). Methods. Anthropometry, blood pressure (BP) measurement, immunoassay (C-reactive protein), biochemical blood analysis (lipid, carbohydrate metabolism parameters, QOL determination (questionnaire Sf-36). Results. In patients with comorbidity of pathologies (presence of AH, t2DM, CKD, CAD, obesity), there was a decrease in assessments in almost all indicators of QOL, and especially significant limitations in the performance of daily activities due to both physical and mental state. Conclusion. The degree of AH in patients with t2DM decreased QOL of physical activity, role-physical functioning, pain and general health, reflecting physical health, as well as mental health, including vitality, social activity, role emotional functioning. T2DM in patients with AH significantly worsens QOL of this category of patients as in physical component summary and mental component summary. The indicators of QOL are significantly affected by the duration of t2DM, as well as the degree of compensation. Achievement of the target BP levels in patients with AH with t2DM shows an improvement in a number of QOL parameters and makes it possible to recommend the Sf-36 questionnaire as a criterion for the effectiveness of the therapy.

Development of the Teaching Interpersonal Skills for Telehealth Checklist

2021 ◽  
pp. 016327872199283
Author(s):  
Beverly W. Henry ◽  
Danica Billingsly ◽  
Derryl E. Block ◽  
Joseph Ehrmann
Keyword(s):  
Interpersonal Skills ◽  
Intraclass Correlation ◽  
Test Validity ◽  
Kappa Statistic ◽  
Order Effects ◽  
Response Patterns ◽  
Validity And Reliability ◽  
Communication Behaviors ◽  
Multi Stage ◽  
Test Retest Reliability

While interpersonal skills in telehealth may positively impact clinical practice, patient engagement and outcomes, assessment strategies are lacking. We conducted a multi-stage iterative approach to develop and test validity and reliability of the Teaching Interpersonal Skills in Telehealth checklist (TIPS-TC). First, we identified observable communication behaviors from the literature. Second, we surveyed telehealth managers and researchers (N = 11) to rate appropriateness of potential checklist items. Level of agreement (35%–91%) and Kappa statistic (0.18–0.89) confirmed items to be retained and identified items to modify. Based on response patterns and comments, we reduced 44 items to 12 critical checklist behaviors. Third, student clinicians used the checklist with video telehealth consultations and provided feedback. Fourth, we conducted reliability testing with practitioners and administrators (N = 68) who completed the TIPS-TC for two versions of a telehealth scenario. Strong interrater reliability intraclass correlation coefficient (ICC) and test-retest reliability ICC (both p < .001), along with non-significant findings of order effects supported the checklist as an acceptable instrument to differentiate high skill from low skill telehealth sessions. The TIPS-TC offers an evidence-based approach to assessing interpersonal skills in telehealth to help evaluate clinician competence and tailor learning activities across disciplinary roles.

scholarly journals A prescribed walking regimen plus arginine supplementation improves function and quality of life for patients with pulmonary arterial hypertension: a pilot study

2017 ◽  
Vol 8 (1) ◽  
pp. 204589321774396 ◽  
Author(s):  
Mary Beth Brown ◽  
Attie Kempf ◽  
Catherine M. Collins ◽  
Gary M. Long ◽  
Matthew Owens ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Current Evidence ◽  
Proof Of Concept ◽  
Concept Study ◽  
Sf 36 ◽  
Pulmonary Arterial ◽  
Arginine Supplementation

Current evidence suggests that exercise training is beneficial in pulmonary arterial hypertension (PAH). Unfortunately, the standard supervised, hospital-based programs limit patient accessibility to this important intervention. Our proof-of-concept study aimed to provide insight into the usefulness of a prescribed walking regimen along with arginine supplementation to improve outcomes for patients with PAH. Twelve PAH patients (all women) in New York Heart Association (NYHA) functional class (FC) II (n = 7) or III (n = 5) and in stable condition for ≥ 3 months were enrolled. Patients performed home- and fitness-center- based walking at 65–75% heart rate (HR) reserve for 45 min, six sessions/week for 12 weeks. Concomitant L-arginine supplementation (6000 mg/day) was provided to maximize beneficial endothelial training adaptations. Cardiopulmonary exercise testing, 6-min walk testing (6MWT), echocardiography, laboratory studies, and quality of life (QoL) survey (SF-36) were performed at baseline and 12 weeks. Eleven patients completed the study (72 session adherence rate = 96 ± 3%). Objective improvement was demonstrated by the 6MWT distance (increased by 40 ± 13 m, P = 0.01), VO2max (increased by 2 ± 0.7 mL/kg/min, P = 0.02), time-to-VO2max (increased by 2.5 ± 0.6 min, P = 0.001), VO2 at anaerobic threshold (increased by 1.3 ± 0.5 mL/kg/min, P = 0.04), HR recovery (reduced by 68 ± 23% in slope, P = 0.01), and SF-36 subscales of Physical Functioning and Energy/Fatigue (increased by 70 ± 34% and 74 ± 34%, respectively, P < 0.05). No adverse events occurred, and right ventricular function and brain natriuretic peptide levels remained stable, suggesting safety of the intervention. This proof-of-concept study indicates that a simple walking regimen with arginine supplementation is a safe and efficacious intervention for clinically stable PAH patients, with gains in objective function and QoL measures. Further investigation in a randomized controlled trial is warranted.

OP443 Evaluating The Value Of Endovascular Innovations For Aortic Valve Replacement Through Clinical Benefits, Patient-reported Outcomes And Resource Consumption.

2021 ◽  
Vol 37 (S1) ◽  
pp. 17-17
Author(s):  
Eduardo Pinar ◽  
Juan García de Lara ◽  
José Hurtado ◽  
Miguel Robles ◽  
Gunnar Leithold ◽  
...  
Keyword(s):  
High Risk ◽  
Aortic Valve ◽  
Short Form ◽  
Systematic Evaluation ◽  
Special Importance ◽  
Economic Modelling ◽  
Sf 36 ◽  
Patient Reported ◽  
Clinical Benefits ◽  
Sapien 3

IntroductionThe use of most recent Transcatheter aortic valve implants (TAVI) in the treatment of symptomatic severe aortic stenosis (SAS) is evolving with expanded indications from inoperable/high-risk to intermediate and low risk patients. Consequently, TAVI outcomes must be monitored to highlight its value under real-world conditions. Our aim was to prospectively evaluate TAVI (SAPIEN 3) outcomes in terms of patient's health-related quality of life (HRQoL), clinical outcomes, and healthcare resource utilization (HRU).MethodsAn observational prospective study including all consecutive patients with SAS undergoing a transcatheter valve implantation with Edwards SAPIEN 3 valve (transfemoral access) was conducted in full accordance with clinical guidelines from the European Society of Cardiology. Patients were evaluated before the intervention (baseline), at discharge, and after one, six and twelve months from the implant. A thoughtful and systematic evaluation of patients’ HRQoL (EQ-5D 5L, the Short Form-36 Health Survey -SF-36- and the Kansas City Cardiomyopathy Questionnaire -KCCQ-), clinical endpoints (that is, cardiovascular mortality, and rates of stroke, major bleeding, myocardial infarction, and re-hospitalization), echocardiographic measurements, and HRU (that is, Length of stay-LOS- in ward/intensive care unit -ICU-) was implemented. Multivariate regression models were applied to test outcomes while controlling key risk factors (that is, patient’ severity at baseline).ResultsA total of seventy-six patients (fifty percent female, fifty-five percent of intermediate-high risk) with a mean age of 82.1 ± 4.78 years were included. Implant success was 97.34% and cardiovascular death was 2.6% at one year. Significant reductions in mean and maximum gradients were achieved and maintained during follow-up. Mean LOS in ward (5.2 ± 4.0days) and ICU (0.22 ± 0.64 days) were low. Statistically significant improvements were detected in the KCCQ overall summary scores, EQ-5D, and SF-36 (Physical component summary) - all adjusted - p < 0.05 - after the intervention.ConclusionsTAVI represents a safe and effective innovation for SAS with clinical benefits translated into significant improvements in terms of HRQoL. Besides, the low HRU provides new insights for health-economic modelling and the optimization of limited resources of special importance under current pandemic situation.

Sign in / Sign up

Export Citation Format

Share Document